A股異動 | 雅本化學(300261.SZ)再度觸及漲停 公司提示風險
格隆匯12月28日丨雅本化學(300261.SZ)今日盤初再度觸及漲停,現漲幅收窄至17.66%,報18.79元創歷史新高,近7個交易日累計漲幅達155%,最新總市值181億元。雅本化學27日晚間發佈公吿稱,公司股價短期內漲幅較大,但生產經營情況未發生明顯變化。公司關注到近期互動易平台投資者對於公司卡龍酸酐及其衍生產品的關注度較高,針對相關情況作出如下澄清及風險提示:截止至公吿披露日,公司未與輝瑞公司簽署任何合作協議,與其不存在任何合作關係,未向輝瑞公司供應卡龍酸酐及其衍生產品。公司卡龍酸酐及其衍生產品的客户主要為國內客户及印度客户,無法確定公司卡龍酸酐及其衍生產品是否間接供給輝瑞公司。公司卡龍酸酐及其衍生產品本年度銷售收入佔公司本年度營業總收入的比例約為0.5%-2%,佔比較小,不會對公司業績產生重大影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.